ALB and cancer: Using statistical analysis of whole-genome sequences across a diverse collection of cancers, they determined that other tumor types harbor similarly prevalent hotspots of noncoding somatic indel mutations, targeting lineage-defining genes (i.e., ALB, TG, and LIPF) [5].